Study has documented that the median time from the first dose of palbociclib to the appearance of neutropenia was 15 days,50 which was earlier than the occurrence of CDK4/6i‐related PAEs in the palbociclib group in our study. The gene discussed is CDK4; the disease is Decreased total neutrophil count.